BackDeep Medicine Acquisition Overview
Deep Medicine Acquisition Corp - Class A

Deep Medicine Acquisition Debt to Equity

Latest debt-to-equity ratio for Deep Medicine Acquisition: 4.96 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

4.96

Debt to Equity

4.96

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Deep Medicine Acquisition (DMAQ) FAQ

Deep Medicine Acquisition posts a debt-to-equity ratio of 4.96. That is above the sector sector average of 0.2. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a debt-to-equity ratio near 0.2 is typical. Deep Medicine Acquisition's 4.96 is higher that level. That is roughly 2371.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Deep Medicine Acquisition's debt-to-equity ratio of 4.96 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for DMAQ's debt-to-equity ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 0.2), and (3) consistency with growth and profitability. This page covers the first two; Deep Medicine Acquisition's other metric pages and overview cover the third.